scholarly article | Q13442814 |
P50 | author | Karl Deisseroth | Q935993 |
Konstantinos Meletis | Q42787236 | ||
Stephanie Jones | Q42860321 | ||
Marie Carlén | Q58764436 | ||
Jessica A. Cardin | Q64942409 | ||
P2093 | author name string | M Sheng | |
L-H Tsai | |||
C I Moore | |||
C Rühlmann | |||
K Futai | |||
D Vierling-Claassen | |||
J H Siegle | |||
P2860 | cites work | Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia | Q22241679 |
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia | Q24293245 | ||
Neuregulin 1 and susceptibility to schizophrenia | Q24616921 | ||
Driving fast-spiking cells induces gamma rhythm and controls sensory responses | Q24627041 | ||
A developmental switch in the response of DRG neurons to ETS transcription factor signaling | Q24791095 | ||
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus | Q24797230 | ||
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 | Q28282369 | ||
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory | Q28300376 | ||
The gamma cycle | Q28305488 | ||
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 | ||
Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. | Q28512788 | ||
Requirement for hippocampal CA3 NMDA receptors in associative memory recall | Q28593732 | ||
Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders | Q29617936 | ||
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
Recent advances in the phencyclidine model of schizophrenia | Q29618917 | ||
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance | Q29619163 | ||
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks | Q29619466 | ||
Gamma frequency-range abnormalities to auditory stimulation in schizophrenia | Q30481594 | ||
Constitutively active Rap2 transgenic mice display fewer dendritic spines, reduced extracellular signal-regulated kinase signaling, enhanced long-term depression, and impaired spatial learning and fear extinction | Q30486818 | ||
Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment | Q30489759 | ||
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures | Q30491325 | ||
NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness | Q33496712 | ||
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes | Q33556077 | ||
Cognition in mouse models of schizophrenia susceptibility genes | Q33707698 | ||
The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia | Q33725853 | ||
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons | Q34197064 | ||
Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice | Q34217453 | ||
Efferent neurons and suspected interneurons in S-1 vibrissa cortex of the awake rabbit: receptive fields and axonal properties | Q34537942 | ||
Stimulus-dependent gamma (30-50 Hz) oscillations in simple and complex fast rhythmic bursting cells in primary visual cortex | Q34554225 | ||
Neuronal gamma-band synchronization as a fundamental process in cortical computation | Q34978196 | ||
Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia | Q35544339 | ||
Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia | Q37090102 | ||
The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia | Q37194179 | ||
Sensorimotor gating and schizophrenia. Human and animal model studies | Q38140814 | ||
Word and tone working memory deficits in schizophrenia | Q38548324 | ||
Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study | Q38565139 | ||
Cellular bases of hippocampal EEG in the behaving rat. | Q40162709 | ||
A role for inhibition in shaping the temporal flow of information in prefrontal cortex | Q40665351 | ||
Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine | Q43503784 | ||
Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task | Q43555258 | ||
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia | Q44045578 | ||
Neuropsychological function in schizophrenia. Selective impairment in memory and learning | Q44140683 | ||
Working memory in schizophrenia: a meta-analysis. | Q44637809 | ||
Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms | Q44918465 | ||
Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats | Q44963581 | ||
N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia | Q46241563 | ||
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia | Q46505377 | ||
Hebbian LTP in feed-forward inhibitory interneurons and the temporal fidelity of input discrimination | Q46529346 | ||
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients | Q46724711 | ||
N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex | Q46893804 | ||
Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. | Q46981404 | ||
Differential modulation of CA1 and dentate gyrus interneurons during exploration of novel environments | Q47590360 | ||
A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. | Q47770430 | ||
A mechanism for generation of long-range synchronous fast oscillations in the cortex | Q47915340 | ||
Increased gamma- and decreased delta-oscillations in a mouse deficient for a potassium channel expressed in fast-spiking interneurons | Q48094543 | ||
Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior | Q48274810 | ||
Increased inhibitory input to CA1 pyramidal cells alters hippocampal gamma frequency oscillations in the MK-801 model of acute psychosis. | Q48337699 | ||
Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation. | Q48347916 | ||
Working memory related gamma oscillations in schizophrenia patients. | Q48425014 | ||
A somatotopic map of vibrissa motion direction within a barrel column. | Q48612420 | ||
The competitive NMDA antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats | Q48825193 | ||
A role for NMDA-receptor channels in working memory. | Q52034658 | ||
The development of parvalbumin-immunoreactivity in the neocortex of the mouse. | Q52214212 | ||
Transformations towards the normal distribution of broad band spectral parameters of the EEG | Q52731582 | ||
Neural correlates of vibrissa resonance; band-pass and somatotopic representation of high-frequency stimuli | Q60145853 | ||
Cellular bases of hippocampal EEG in the behaving rat | Q105583587 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 537-548 | |
P577 | publication date | 2011-04-05 | |
P1433 | published in | Molecular Psychiatry | Q6895973 |
P1476 | title | A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior | |
P478 | volume | 17 |
Q47719281 | 22q11.2 Deletion Syndrome Is Associated With Impaired Auditory Steady-State Gamma Response |
Q40031007 | 40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors |
Q39100348 | A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex. |
Q92536147 | A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD |
Q58699765 | A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology |
Q98630860 | A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients |
Q30652639 | A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling |
Q94581146 | A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology |
Q38122300 | A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo |
Q92528124 | Aberrant expression of S-SCAM causes the loss of GABAergic synapses in hippocampal neurons |
Q38568415 | Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia |
Q39427551 | Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice |
Q36247426 | Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex |
Q41159075 | Afferent specific role of NMDA receptors for the circuit integration of hippocampal neurogliaform cells |
Q30727742 | Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism |
Q89218717 | Alterations in cortical interneurons and cognitive function in schizophrenia |
Q47310571 | Altered Cortical Ensembles in Mouse Models of Schizophrenia. |
Q47557547 | Altered avalanche dynamics in a developmental NMDAR hypofunction model of cognitive impairment |
Q47118295 | Altered intrinsic and extrinsic connectivity in schizophrenia |
Q41763196 | Altered modulation of gamma oscillation frequency by speed of visual motion in children with autism spectrum disorders. |
Q49065170 | Altered resonance properties of somatosensory responses in mice deficient for the schizophrenia risk gene Neuregulin 1. |
Q35563515 | An excitatory synapse hypothesis of depression |
Q33990683 | Association of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophrenia |
Q104570381 | Astroglial cells as neuroendocrine targets in forebrain development: implications for sex differences in psychiatric disease |
Q30372221 | Atypical visual and somatosensory adaptation in schizophrenia-spectrum disorders. |
Q30454156 | Augmented gamma band auditory steady-state responses: support for NMDA hypofunction in schizophrenia |
Q35702202 | Baseline gamma power during auditory steady-state stimulation in schizophrenia |
Q64924509 | Blocking NMDAR Disrupts Spike Timing and Decouples Monkey Prefrontal Circuits: Implications for Activity-Dependent Disconnection in Schizophrenia. |
Q30435025 | Brain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model |
Q47618895 | Brain-derived neurotrophic factor haploinsufficiency impairs high-frequency cortical oscillations in mice |
Q91867564 | Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type? |
Q33819365 | Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. |
Q48099364 | Cell-specific gain modulation by synaptically released zinc in cortical circuits of audition |
Q38636247 | Cellular and circuit models of increased resting-state network gamma activity in schizophrenia |
Q57815219 | Chd2 Is Necessary for Neural Circuit Development and Long-Term Memory |
Q37177032 | Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivo |
Q27027692 | Circuit dynamics of adaptive and maladaptive behaviour |
Q30455798 | Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia |
Q35613651 | Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia |
Q90732283 | Computational Modeling of Genetic Contributions to Excitability and Neural Coding in Layer V Pyramidal Cells: Applications to Schizophrenia Pathology |
Q42949279 | Computational study of NMDA conductance and cortical oscillations in schizophrenia |
Q37292590 | Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia |
Q30455334 | Contribution of NMDA receptor hypofunction in prefrontal and cortical excitatory neurons to schizophrenia-like phenotypes |
Q35042193 | Contribution of parvalbumin and somatostatin-expressing GABAergic neurons to slow oscillations and the balance in beta-gamma oscillations across cortical layers |
Q30453487 | Controlling the elements: an optogenetic approach to understanding the neural circuits of fear |
Q36307544 | Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments |
Q48119066 | Cortical Local Field Potential Power Is Associated with Behavioral Detection of Near-threshold Stimuli in the Rat Whisker System: Dissociation between Orbitofrontal and Somatosensory Cortices |
Q26853430 | Cortical inhibition, excitation, and connectivity in schizophrenia: a review of insights from transcranial magnetic stimulation |
Q34060159 | Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia |
Q37561567 | Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases. |
Q35212508 | Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations |
Q37203598 | Decreased haemodynamic response and decoupling of cortical gamma-band activity and tissue oxygen perfusion after striatal interleukin-1 injection |
Q53435833 | Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes. |
Q83227405 | Dendritic NMDA receptors in parvalbumin neurons enable strong and stable neuronal assemblies |
Q30453949 | Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations |
Q48748321 | Direct excitation of parvalbumin-positive interneurons by M1 muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition. |
Q40142644 | Disrupted Cortical State Regulation in a Rat Model of Fragile X Syndrome. |
Q30402048 | Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders |
Q38117750 | Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action |
Q43077901 | Distinct Physiological Maturation of Parvalbumin-Positive Neuron Subtypes in Mouse Prefrontal Cortex |
Q28481383 | Dopamine D4 receptor activation increases hippocampal gamma oscillations by enhancing synchronization of fast-spiking interneurons |
Q36973467 | Dopamine, cognitive function, and gamma oscillations: role of D4 receptors. |
Q35670062 | Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity |
Q94664128 | Downregulation of parvalbumin expression in the prefrontal cortex during adolescence causes enduring prefrontal disinhibition in adulthood |
Q54117049 | Dynamic ErbB4 Activity in Hippocampal-Prefrontal Synchrony and Top-Down Attention in Rodents. |
Q37398135 | Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function |
Q45056546 | Dynamics of spiking neurons: between homogeneity and synchrony |
Q30433522 | Early auditory gamma-band responses in patients at clinical high risk for schizophrenia |
Q47812296 | Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats |
Q47791105 | Effects of Hallucinogens on Neuronal Activity |
Q47832635 | Effects of Ketamine on Basal Gamma Band Oscillation and Sensory Gating in Prefrontal Cortex of Awake Rats |
Q41187872 | Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans |
Q50643480 | Effects of aberrant gamma frequency oscillations on prepulse inhibition. |
Q37057373 | Effects of neonatal stress on gamma oscillations in hippocampus. |
Q35132662 | Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviors |
Q30437684 | Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression |
Q38440780 | Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis |
Q57296424 | Electrophysiological evidence for abnormal glutamate-GABA association following psychosis onset |
Q33647885 | Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia |
Q38270002 | Encoding of fear learning and memory in distributed neuronal circuits. |
Q41774176 | Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia |
Q39121207 | Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators |
Q39412337 | Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms |
Q47633556 | Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice |
Q37955547 | Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? |
Q30757195 | Excitation-Transcription Coupling in Parvalbumin-Positive Interneurons Employs a Novel CaM Kinase-Dependent Pathway Distinct from Excitatory Neurons |
Q42945208 | Experience-dependent remodeling of basket cell networks in the dentate gyrus |
Q34069564 | Fast oscillatory activity in the anterior cingulate cortex: dopaminergic modulation and effect of perineuronal net loss |
Q42359468 | Frequency of gamma oscillations in humans is modulated by velocity of visual motion |
Q45939687 | Functions and dysfunctions of neocortical inhibitory neuron subtypes. |
Q38435508 | G Protein-Gated K+ Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning. |
Q35770888 | GABA system dysfunction in autism and related disorders: from synapse to symptoms |
Q33573692 | GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome. |
Q24625065 | GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. |
Q41873896 | GABAergic circuit dysfunctions in neurodevelopmental disorders |
Q36668325 | GABAergic control of depression-related brain states |
Q26825288 | GABAergic interneurons shape the functional maturation of the cortex |
Q98784957 | GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia |
Q96817727 | Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia |
Q36990973 | Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities |
Q41915981 | Gamma oscillations are generated locally in an attention-related midbrain network |
Q27026328 | Gamma oscillations in the midbrain spatial attention network: linking circuits to function |
Q27305944 | Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5/6(+/-) mice. |
Q30597588 | Gamma-range synchronization of fast-spiking interneurons can enhance detection of tactile stimuli. |
Q61449455 | Gene-Environment Interaction in a Conditional NMDAR-Knockout Model of Schizophrenia |
Q47848432 | Genetic deletion of NMDA receptors suppresses GABAergic synaptic transmission in two distinct types of central neurons |
Q30362301 | GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia |
Q38838637 | Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine |
Q38153036 | High-frequency neural oscillations and visual processing deficits in schizophrenia |
Q26829587 | High-frequency oscillations and the neurobiology of schizophrenia |
Q47734973 | Hippocampal GABAergic Inhibitory Interneurons |
Q30439924 | How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia |
Q37424600 | Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells |
Q50531661 | Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia. |
Q26830533 | Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits |
Q36678412 | Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations |
Q39257224 | Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective |
Q35541492 | In vitro gamma oscillations following partial and complete ablation of δ subunit-containing GABAA receptors from parvalbumin interneurons |
Q33624988 | In vivo optogenetic identification and manipulation of GABAergic interneuron subtypes |
Q39370161 | Increased BOLD Signals Elicited by High Gamma Auditory Stimulation of the Left Auditory Cortex in Acute State Schizophrenia. |
Q47744597 | Increased anxiety-like behavior and selective learning impairments are concomitant to loss of hippocampal interneurons in the presymptomatic SOD1(G93A) ALS mouse model. |
Q30359987 | Increased stereotypy in conditional Cxcr4 knockout mice. |
Q58549766 | Inferring neural circuit properties from optogenetic stimulation |
Q92794524 | Insoluble Aβ overexpression in an App knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, affecting anxiety-related behaviours |
Q50240247 | Interneuron Deficit Associates Attenuated Network Synchronization to Mismatch of Energy Supply and Demand in Aging Mouse Brains. |
Q90603837 | Interneuron NMDA receptor ablation induces hippocampus-prefrontal cortex functional hypoconnectivity after adolescence in a mouse model of schizophrenia |
Q34247716 | Interneuron dysfunction in psychiatric disorders |
Q94562279 | Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia |
Q90685299 | Isoflurane and ketamine differentially influence spontaneous and evoked laminar electrophysiology in mouse V1 |
Q30421694 | Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice |
Q30542045 | Ketamine alters oscillatory coupling in the hippocampus |
Q92480214 | Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines |
Q51766804 | Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. |
Q91600783 | Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression |
Q99615816 | Ketamine normalizes high-gamma power in the anterior cingulate cortex in a rat chronic pain model |
Q30436342 | Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes. |
Q27338525 | Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801 |
Q57802466 | Lamina-specific cortical dynamics in human visual and sensorimotor cortices |
Q36020646 | Learning and memory depend on fibroblast growth factor receptor 2 functioning in hippocampus |
Q40813055 | Lentiviral expression of GAD67 and CCK promoter-driven opsins to target interneurons in vitro and in vivo. |
Q43223717 | Long-range recruitment of Martinotti cells causes surround suppression and promotes saliency in an attractor network model |
Q94452209 | Long-term potentiation prevents ketamine-induced aberrant neurophysiological dynamics in the hippocampus-prefrontal cortex pathway in vivo |
Q41082140 | Losing control under ketamine: suppressed cortico-hippocampal drive following acute ketamine in rats |
Q38064198 | Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia |
Q41876109 | Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists |
Q64929509 | Modeling Schizophrenia's Abnormal Cortical Neural Synchrony in Monkeys. |
Q89963801 | Modulation of Hippocampal Gamma Oscillations by Dopamine in Heterozygous Reeler Mice in vitro |
Q37610754 | Modulation of excitation on parvalbumin interneurons by neuroligin-3 regulates the hippocampal network |
Q58698014 | Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics |
Q87889225 | Multiple long-range inputs evoke NMDA currents in prefrontal cortex fast-spiking interneurons |
Q57154226 | N-Methyl D-aspartate receptor subunit signaling in fear extinction |
Q49466202 | N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI. |
Q64065882 | NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality |
Q42644166 | NMDA receptor activation strengthens weak electrical coupling in mammalian brain |
Q36245009 | NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia |
Q35586357 | NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism |
Q57460089 | NMDA-receptor antibodies alter cortical microcircuit dynamics |
Q92649238 | NMDAR Hypofunction Animal Models of Schizophrenia |
Q38310750 | Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges |
Q54979493 | Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK. |
Q56967279 | Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons |
Q36167626 | Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors |
Q48407869 | Neuroinflammation-Induced Downregulation of Hippocampacal Neuregulin 1-ErbB4 Signaling in the Parvalbumin Interneurons Might Contribute to Cognitive Impairment in a Mouse Model of Sepsis-Associated Encephalopathy. |
Q92886214 | Neuroprotective effect of microglia against impairments of auditory steady-state response induced by anti-P IgG from SLE patients in naïve mice |
Q64063044 | Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders |
Q47837913 | Neurotransmitter deficits from frontotemporal lobar degeneration |
Q46119178 | Norepinephrine ignites local hotspots of neuronal excitation: How arousal amplifies selectivity in perception and memory |
Q36475273 | On the photovoltaic effect in local field potential recordings |
Q38211498 | Optogenetic approaches for investigating neural pathways implicated in schizophrenia and related disorders. |
Q34660762 | Optogenetic dissection of medial prefrontal cortex circuitry |
Q97636079 | Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia |
Q92078371 | Optogenetic stimulation of basal forebrain parvalbumin neurons modulates the cortical topography of auditory steady-state responses |
Q37346030 | Optogenetically evoked gamma oscillations are disturbed by cocaine administration |
Q38029530 | Optogenetics in neuroscience: what we gain from studies in mammals |
Q34025794 | Ovarian cycle-linked plasticity of δ-GABAA receptor subunits in hippocampal interneurons affects γ oscillations in vivo |
Q34383492 | PGC-1α provides a transcriptional framework for synchronous neurotransmitter release from parvalbumin-positive interneurons |
Q54962793 | PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders. |
Q30412701 | Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia |
Q30578270 | Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits |
Q58718220 | Parvalbumin expression and gamma oscillation occurrence increase over time in a neurodevelopmental model of NMDA receptor dysfunction |
Q98156748 | Parvalbumin interneuron vulnerability and brain disorders |
Q43196510 | Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons |
Q40773725 | Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice |
Q28547137 | Phencyclidine Disrupts the Auditory Steady State Response in Rats |
Q36468691 | Prefrontal Parvalbumin Neurons in Control of Attention |
Q30452766 | Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia |
Q30388341 | Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability |
Q39175715 | RNA interference of GluN1 inhibits neuronal rhythmogenesis in the adult inferior olive |
Q38170104 | Rational design of transcranial current stimulation (TCS) through mechanistic insights into cortical network dynamics |
Q92418509 | Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration |
Q34428194 | Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology? |
Q91539339 | Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine |
Q36433570 | Reduced gamma frequency in the medial frontal cortex of aged rats during behavior and rest: implications for age-related behavioral slowing |
Q37394311 | Reduction in cortical gamma synchrony during depolarized state of slow wave activity in mice |
Q41687474 | Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry |
Q28544934 | Relationships among parvalbumin-immunoreactive neuron density, phase-locked gamma oscillations, and autistic/schizophrenic symptoms in PDGFR-β knock-out and control mice |
Q59129268 | Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages |
Q59941623 | Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia |
Q61443765 | Role of cholesterol and sphingolipids in brain development and neurological diseases |
Q47549477 | Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction. |
Q41270317 | Schizophrenia-like phenotypes in mice with NMDA receptor ablation in intralaminar thalamic nucleus cells and gene therapy-based reversal in adults |
Q57292683 | Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity |
Q47677836 | Schizophrenia: Basic and Clinical |
Q57720830 | Selective Prefrontal Disinhibition in a Roving Auditory Oddball Paradigm Under N-Methyl-D-Aspartate Receptor Blockade |
Q30586288 | Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. |
Q37292555 | Sensory encoding in Neuregulin 1 mutants |
Q30354621 | Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models. |
Q41170329 | Sequence of Molecular Events during the Maturation of the Developing Mouse Prefrontal Cortex |
Q35514531 | Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons |
Q26824535 | Simultaneous EEG and fMRI: towards the characterization of structure and dynamics of brain networks |
Q57481870 | Somatostatin Interneurons Facilitate Hippocampal-Prefrontal Synchrony and Prefrontal Spatial Encoding |
Q30355619 | Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. |
Q27313316 | Spatio-temporal dynamics of adaptation in the human visual system: a high-density electrical mapping study |
Q30377860 | Spontaneous Gamma Activity in Schizophrenia. |
Q98564826 | Stimulus-specific regulation of visual oddball differentiation in posterior parietal cortex |
Q26825577 | Synapse-specific contributions in the cortical pathology of schizophrenia |
Q26829347 | Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia |
Q36128314 | Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression |
Q30380519 | Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia. |
Q34624232 | Tasks for inhibitory interneurons in intact brain circuits |
Q64928145 | Test-retest reliability of time-frequency measures of auditory steady-state responses in patients with schizophrenia and healthy controls. |
Q30661863 | Tet1 is critical for neuronal activity-regulated gene expression and memory extinction |
Q38391287 | The 40-Hz auditory steady-state response: a selective biomarker for cortical NMDA function |
Q91687465 | The Modulation of Gamma Oscillations by Methamphetamine in Rat Hippocampal Slices |
Q83228811 | The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero |
Q30367844 | The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function. |
Q64891767 | The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia. |
Q91767794 | The Role of Parvalbumin-positive Interneurons in Auditory Steady-State Response Deficits in Schizophrenia |
Q38495111 | The challenge of understanding the brain: where we stand in 2015. |
Q91779468 | The dynamics of disordered dialogue: Prefrontal, hippocampal and thalamic miscommunication underlying working memory deficits in schizophrenia |
Q28081110 | The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia |
Q58603825 | The role of functional and structural interhemispheric auditory connectivity for language lateralization - A combined EEG and DTI study |
Q27023087 | The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia |
Q33626171 | The translationally relevant mouse model of the 15q13.3 microdeletion syndrome reveals deficits in neuronal spike firing matching clinical neurophysiological biomarkers seen in schizophrenia. |
Q35352808 | Tools for probing local circuits: high-density silicon probes combined with optogenetics |
Q88236229 | Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome |
Q38370696 | Translational psychiatry--light at the end of the tunnel. |
Q39140436 | Translational use of event-related potentials to assess circuit integrity in ASD. |
Q30635024 | Visual recognition memory, manifested as long-term habituation, requires synaptic plasticity in V1 |
Q38249908 | What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit. |
Q34355386 | Working memory impairment in calcineurin knock-out mice is associated with alterations in synaptic vesicle cycling and disruption of high-frequency synaptic and network activity in prefrontal cortex |
Q87273378 | [Significance of clinical electroencephalogram in psychiatry] |
Search more.